Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-28
1998-05-05
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544283, 544293, A61K 31495, A61K 31505, C07D23970, C07D23994
Patent
active
057474982
ABSTRACT:
The invention relates to compounds of the formula ##STR1## and to pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, n and m are as defined herein. The compounds of formula I are useful in the treatment of hyperproliferative diseases, such as cancer. The invention further relates to processes of making the compounds of formula I and to methods of using such compounds in the treatment of hyperproliferative diseases.
REFERENCES:
patent: 5256781 (1993-10-01), Primeau
patent: 5457105 (1995-10-01), Barker
patent: 5475001 (1995-12-01), Barker
Arnold Lee Daniel
Schnur Rodney Caughren
Ginsburg Paul H.
Grumbling Matthew V.
Pfizer Inc.
Richardson Peter C.
Zielinski Bryan C.
LandOfFree
Alkynyl and azido-substituted 4-anilinoquinazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkynyl and azido-substituted 4-anilinoquinazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkynyl and azido-substituted 4-anilinoquinazolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54937